LIVANOVA PLC (LIVN) Stock Fundamental Analysis

NASDAQ:LIVN • GB00BYMT0J19

70.6 USD
-0.4 (-0.56%)
At close: Feb 27, 2026
70.6 USD
0 (0%)
After Hours: 2/27/2026, 8:15:43 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall LIVN gets a fundamental rating of 5 out of 10. We evaluated LIVN against 185 industry peers in the Health Care Equipment & Supplies industry. LIVN has an average financial health and profitability rating. LIVN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • LIVN had positive earnings in the past year.
  • In the past year LIVN had a positive cash flow from operations.
  • In multiple years LIVN reported negative net income over the last 5 years.
  • In the past 5 years LIVN always reported a positive cash flow from operatings.
LIVN Yearly Net Income VS EBIT VS OCF VS FCFLIVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • LIVN's Return On Assets of -8.50% is fine compared to the rest of the industry. LIVN outperforms 63.78% of its industry peers.
  • LIVN has a Return On Equity of -18.78%. This is in the better half of the industry: LIVN outperforms 61.08% of its industry peers.
  • The Return On Invested Capital of LIVN (8.35%) is better than 84.86% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LIVN is significantly below the industry average of 8.75%.
  • The 3 year average ROIC (3.45%) for LIVN is below the current ROIC(8.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.5%
ROE -18.78%
ROIC 8.35%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
LIVN Yearly ROA, ROE, ROICLIVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

  • With an excellent Operating Margin value of 14.94%, LIVN belongs to the best of the industry, outperforming 82.70% of the companies in the same industry.
  • In the last couple of years the Operating Margin of LIVN has grown nicely.
  • With a decent Gross Margin value of 68.50%, LIVN is doing good in the industry, outperforming 75.14% of the companies in the same industry.
  • In the last couple of years the Gross Margin of LIVN has remained more or less at the same level.
Industry RankSector Rank
OM 14.94%
PM (TTM) N/A
GM 68.5%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
LIVN Yearly Profit, Operating, Gross MarginsLIVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • LIVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • LIVN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for LIVN has been increased compared to 5 years ago.
  • The debt/assets ratio for LIVN has been reduced compared to a year ago.
LIVN Yearly Shares OutstandingLIVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
LIVN Yearly Total Debt VS Total AssetsLIVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • LIVN has an Altman-Z score of 1.93. This is not the best score and indicates that LIVN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LIVN has a Altman-Z score (1.93) which is in line with its industry peers.
  • The Debt to FCF ratio of LIVN is 2.26, which is a good value as it means it would take LIVN, 2.26 years of fcf income to pay off all of its debts.
  • LIVN has a better Debt to FCF ratio (2.26) than 85.95% of its industry peers.
  • A Debt/Equity ratio of 0.30 indicates that LIVN is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.30, LIVN is in line with its industry, outperforming 51.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Altman-Z 1.93
ROIC/WACC0.96
WACC8.68%
LIVN Yearly LT Debt VS Equity VS FCFLIVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • LIVN has a Current Ratio of 1.33. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.33, LIVN is not doing good in the industry: 78.38% of the companies in the same industry are doing better.
  • LIVN has a Quick Ratio of 1.12. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.12, LIVN is doing worse than 73.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.12
LIVN Yearly Current Assets VS Current LiabilitesLIVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 15.73% over the past year.
  • The Earnings Per Share has been growing by 25.16% on average over the past years. This is a very strong growth
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.15%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.22% on average over the next years. This is quite good.
  • LIVN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.71% yearly.
EPS Next Y8.11%
EPS Next 2Y7.93%
EPS Next 3Y9.97%
EPS Next 5Y13.22%
Revenue Next Year6.68%
Revenue Next 2Y6.6%
Revenue Next 3Y6.86%
Revenue Next 5Y6.71%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LIVN Yearly Revenue VS EstimatesLIVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
LIVN Yearly EPS VS EstimatesLIVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.10, which indicates a rather expensive current valuation of LIVN.
  • Based on the Price/Earnings ratio, LIVN is valued cheaply inside the industry as 85.95% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of LIVN to the average of the S&P500 Index (27.10), we can say LIVN is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 16.74, which indicates a correct valuation of LIVN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LIVN indicates a rather cheap valuation: LIVN is cheaper than 86.49% of the companies listed in the same industry.
  • LIVN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.1
Fwd PE 16.74
LIVN Price Earnings VS Forward Price EarningsLIVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LIVN is valued cheaply inside the industry as 82.70% of the companies are valued more expensively.
  • LIVN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LIVN is cheaper than 90.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.07
EV/EBITDA 14.9
LIVN Per share dataLIVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LIVN does not grow enough to justify the current Price/Earnings ratio.
  • LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.23
PEG (5Y)0.72
EPS Next 2Y7.93%
EPS Next 3Y9.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • LIVN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

LIVANOVA PLC

NASDAQ:LIVN (2/27/2026, 8:15:43 PM)

After market: 70.6 0 (0%)

70.6

-0.4 (-0.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners105.72%
Inst Owner Change-2.18%
Ins Owners0.28%
Ins Owner Change0.34%
Market Cap3.86B
Revenue(TTM)N/A
Net Income(TTM)-217.38M
Analysts82.35
Price Target73.19 (3.67%)
Short Float %4.48%
Short Ratio4.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)0.25%
PT rev (3m)6.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.38%
EPS NY rev (1m)0%
EPS NY rev (3m)2.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.96%
Valuation
Industry RankSector Rank
PE 18.1
Fwd PE 16.74
P/S 2.86
P/FCF 20.07
P/OCF 15.36
P/B 3.33
P/tB 29.28
EV/EBITDA 14.9
EPS(TTM)3.9
EY5.52%
EPS(NY)4.22
Fwd EY5.97%
FCF(TTM)3.52
FCFY4.98%
OCF(TTM)4.6
OCFY6.51%
SpS24.7
BVpS21.19
TBVpS2.41
PEG (NY)2.23
PEG (5Y)0.72
Graham Number43.12
Profitability
Industry RankSector Rank
ROA -8.5%
ROE -18.78%
ROCE 11.65%
ROIC 8.35%
ROICexc 13.32%
ROICexgc 247.44%
OM 14.94%
PM (TTM) N/A
GM 68.5%
FCFM 14.24%
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.42%
ROICexc growth 3Y38.42%
ROICexc growth 5Y24.6%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.26
Debt/EBITDA 1.42
Cap/Depr 132.33%
Cap/Sales 4.36%
Interest Coverage 250
Cash Conversion 102%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.12
Altman-Z 1.93
F-Score6
WACC8.68%
ROIC/WACC0.96
Cap/Depr(3y)78.91%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.73%
EPS 3Y17.57%
EPS 5Y25.16%
EPS Q2Q%6.17%
EPS Next Y8.11%
EPS Next 2Y7.93%
EPS Next 3Y9.97%
EPS Next 5Y13.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.15%
Revenue Next Year6.68%
Revenue Next 2Y6.6%
Revenue Next 3Y6.86%
Revenue Next 5Y6.71%
EBIT growth 1Y50.76%
EBIT growth 3Y51.09%
EBIT growth 5Y22.46%
EBIT Next Year41.25%
EBIT Next 3Y17.93%
EBIT Next 5Y3.36%
FCF growth 1Y2170.19%
FCF growth 3Y20.82%
FCF growth 5YN/A
OCF growth 1Y532.75%
OCF growth 3Y21.3%
OCF growth 5YN/A

LIVANOVA PLC / LIVN FAQ

Can you provide the ChartMill fundamental rating for LIVANOVA PLC?

ChartMill assigns a fundamental rating of 5 / 10 to LIVN.


Can you provide the valuation status for LIVANOVA PLC?

ChartMill assigns a valuation rating of 6 / 10 to LIVANOVA PLC (LIVN). This can be considered as Fairly Valued.


What is the profitability of LIVN stock?

LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.


What is the financial health of LIVANOVA PLC (LIVN) stock?

The financial health rating of LIVANOVA PLC (LIVN) is 5 / 10.


Can you provide the expected EPS growth for LIVN stock?

The Earnings per Share (EPS) of LIVANOVA PLC (LIVN) is expected to grow by 8.11% in the next year.